Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
BMJ Case Reports
|
December 8, 2021
Sterile tuberculous granuloma in a patient with XDR-TB treated with bedaquiline, pretomanid and linezolid
Pauline Howell, Caryn Upton, Nokuphiwa Mvuna, et al.
Respirology (Carlton, Vic.)
|
January 31, 2025
Tuberculosis: An Update for the Clinician
Saskia Janssen, Melissa Murphy, Caryn Upton, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 21, 2025
Telacebec, A Potent Agent in the Fight Against Tuberculosis: Findings from A Randomized, Phase 2 Clinical Trial and Beyond
Saskia Janssen, Caryn Upton, Veronique R de Jager, et al.
BMC Infectious Diseases
|
February 25, 2021
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial
Anne-Marie Demers, Soyeon Kim, Sara McCallum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 27, 2021
Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational Study
Davit Baliashvili, Neel R Gandhi, Soyeon Kim, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 2, 2024
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, et al.
The Pediatric Infectious Disease Journal
|
March 3, 2022
High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis
Soyeon Kim, Xingye Wu, Michael D Hughes, et al.
The Lancet. Infectious Diseases
|
May 20, 2024
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial
Muge Cevik, Lindsay C Thompson, Caryn Upton, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 21, 2025
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposure
Delia Goletti, Niaz Banaei, Rahul Batra, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
BMJ Case Reports
|
December 8, 2021
Sterile tuberculous granuloma in a patient with XDR-TB treated with bedaquiline, pretomanid and linezolid
Pauline Howell, Caryn Upton, Nokuphiwa Mvuna, et al.
Respirology (Carlton, Vic.)
|
January 31, 2025
Tuberculosis: An Update for the Clinician
Saskia Janssen, Melissa Murphy, Caryn Upton, et al.
American Journal of Respiratory and Critical Care Medicine
|
March 21, 2025
Telacebec, A Potent Agent in the Fight Against Tuberculosis: Findings from A Randomized, Phase 2 Clinical Trial and Beyond
Saskia Janssen, Caryn Upton, Veronique R de Jager, et al.
BMC Infectious Diseases
|
February 25, 2021
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial
Anne-Marie Demers, Soyeon Kim, Sara McCallum, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 27, 2021
Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational Study
Davit Baliashvili, Neel R Gandhi, Soyeon Kim, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 2, 2024
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial
Kamunkhwala Gausi, Elisa H Ignatius, Veronique De Jager, et al.
The Pediatric Infectious Disease Journal
|
March 3, 2022
High Prevalence of Tuberculosis Infection and Disease in Child Household Contacts of Adults With Rifampin-resistant Tuberculosis
Soyeon Kim, Xingye Wu, Michael D Hughes, et al.
The Lancet. Infectious Diseases
|
May 20, 2024
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial
Muge Cevik, Lindsay C Thompson, Caryn Upton, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
December 21, 2025
Accuracy of VIDAS® TB-IGRA in TB patients and individuals with different thresholds of exposure
Delia Goletti, Niaz Banaei, Rahul Batra, et al.
Page
of 1